Back to PO PointState Capital LP
BNTX
Showing 0 of 6 quarters
Position history for POPointState Capital LP's holdings in BioNTech SE
No. PointState Capital exited its BNTX (BioNTech) position in Q1 2022. Its Q4 2021 13F listed 3,908 shares worth $1M. PointState Capital first reported BNTX in Q4 2020 and held it in 5 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.